Healthcare Stocks Doing Well but SMID Biotech Looking a Little Frazzled…Update-3 broad rally
update-3 3/14---A broad relief rally today after a miserable week took the NAZ up 2.61% and the Russell 2000 up 2.42% and the XBI was flat ending the week at the $87 level. And that was good, Our focus lately has been the SMID cap biotech stocks and they were volatile given the backdrop of...
Biotech Rally Coming in Weeks Ahead? Update-2… Powell Talk Soothes Markets
Update-2...3/7/25---The market was headed for more losses on Friday during a bad week from tariff chaos when Chairman Powell came on helping calm markets.The healthcare sector continue to avoid tariff issues but we have a few more rounds including "reciprocal tariffs" that bears watching. We...
Biotech Stocks Stay Strong Through a Period of Uncertainty in the Market…Update-2 Recovery despite geopolitics
2/28/25. Upate 2 2/28...Market recovers despite heated Trump/Zelensky exchange. Healthcare still leads the way but importantly buys come into NAZ stocks in last hour up 1.67%. Some nibbles on SMID lifescience stocks with XBI up 1.85% to $88.71: CPRX, CRNX, NVAX, PTGX, RNA, VCEL. NEW buy and...
Large Cap Biopharmaceutical Metrics and Performance Q1 2025
Large Cap Biopharmaceuticals- Performance Metrics The best performing biopharma stocks YTD were: ABBV up 8.5%, AMGN up 11.8%, AZN up 12%, GILD up 12.7%, LLY up 9.4%, VRTX up 14%. The worst performing biopharmas YTD were: BMY down 4.7%, BIIB, down 10.2%, MRK down 16.6%, PFE. down 3.7%, REGN down...
SMID Biotech Stocks had a Good Week despite crosscurrents
SMID Biotech Stocks Rallied Nicely the Week of 2/13/25 Selected SMID life science stocks had a good week in a bifurcated market. Large cap biopharmas earnings have been strong and comprise the largest healthcare holdings in our portfolio. Political crosscurrents are a concern- uncertainty of...